OptiBiotix Health

OptiBiotix Health EBIT

The EBIT of OptiBiotix Health (OPTI.L) as of Nov 11, 2026 is -3.13 M GBP. In the previous year, EBIT was -2.27 M GBP — a change of 38.22% (lower).

EBIT

-3.13 MGBP

YoY

38.22%

Last updated:

In 2025, OptiBiotix Health's EBIT was -3.13 M GBP, a 38.22% increase from the -2.27 M GBP EBIT recorded in the previous year.

The OptiBiotix Health EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2018
-1.50 M GBP
Jan 1, 2019
-2.17 M GBP
Jan 1, 2020
5.75 M GBP
Jan 1, 2021
6.22 M GBP
Jan 1, 2022
2.44 M GBP
Jan 1, 2023
-1.70 M GBP
Jan 1, 2024
-2.27 M GBP
Jan 1, 2025
-3.13 M GBP
The OptiBiotix Health EBIT history
YEAREBITYoY
-3.13 MGBP+38.22%
-2.27 MGBP+33.69%
-1.70 MGBP-169.44%
2.44 MGBP-60.78%
6.22 MGBP+8.16%
5.75 MGBP-365.57%
-2.17 MGBP+44.56%
-1.50 MGBP-188.44%
1.70 MGBP-211.81%
-1.52 MGBP+6.54%
-1.42 MGBP+191.00%
-489,000.00GBP+91.02%
-256,000.00GBP-84.45%
-1.65 MGBP+42.88%
-1.15 MGBP+2,853.85%
-39,000.00GBP+30.00%
-30,000.00GBP-57.75%
-71,000.00GBP+7.44%
-66,083.00GBP—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

OptiBiotix Health Revenue

OptiBiotix Health Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
514,289.00 GBP
-1.50 M GBP
-1.92 M GBP
Jan 1, 2019
744,883.00 GBP
-2.17 M GBP
-2.37 M GBP
Jan 1, 2020
1.52 M GBP
5.75 M GBP
5.80 M GBP
Jan 1, 2021
2.21 M GBP
6.22 M GBP
6.26 M GBP
Jan 1, 2022
457,000.00 GBP
2.44 M GBP
2.59 M GBP
Jan 1, 2023
644,000.00 GBP
-1.70 M GBP
-2.04 M GBP
Jan 1, 2024
870,000.00 GBP
-2.27 M GBP
-1.81 M GBP
Jan 1, 2025
1.17 M GBP
-3.13 M GBP
-3.89 M GBP

OptiBiotix Health Margins

OptiBiotix Health stock margins

The OptiBiotix Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of OptiBiotix Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for OptiBiotix Health.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
68.35 %
-291.47 %
-373.14 %
Jan 1, 2019
23.47 %
-290.92 %
-317.90 %
Jan 1, 2020
57.77 %
377.86 %
380.96 %
Jan 1, 2021
50.75 %
281.27 %
282.92 %
Jan 1, 2022
53.39 %
534.14 %
566.08 %
Jan 1, 2023
49.69 %
-263.20 %
-316.61 %
Jan 1, 2024
38.05 %
-260.46 %
-207.47 %
Jan 1, 2025
52.66 %
-268.61 %
-333.62 %

OptiBiotix Health Stock analysis

What does OptiBiotix Health do? OptiBiotix Health Plc is a British company founded in 2012 that focuses on the development and marketing of pre- and probiotic products. The company's goal is to improve the health and well-being of people around the world. OptiBiotix Health has developed a unique business model based on identifying new applications for existing nutrients and probiotic bacteria. The company works closely with leading academic institutions to develop innovative technologies and products based on scientific knowledge and clinical studies. An important division of the company is weight management products. OptiBiotix Health has developed a promising approach based on the identification of bacterial strains that can reduce the growth of fat cells and improve metabolism in the body. These bacteria can be found in products such as "SlimBiome," "GoFigure," and "CholBiome." Another area covered by OptiBiotix Health is gastroenterology. The Bonne Santé products include vitamin-rich, fiber-rich, and lactic acid bacteria-rich foods and beverages that keep the digestive system healthy and promote well-being. By using probiotics and prebiotics, the company can also offer products for people with digestive disorders and conditions such as irritable bowel syndrome. OptiBiotix Health also has a health monitoring and diagnostics department that focuses on the discovery of biomarker-based tests. These tests can be used to detect specific diseases and predict the course of diseases. Some of the key products being developed here are "SweetBiotix" and "CardioBiotix." These products aim to reduce the risk of type 2 diabetes and cardiovascular diseases as part of the life science portfolio. OptiBiotix Health's products are distributed worldwide. The company has various agreements with leading manufacturers and distribution partners in Europe, Asia, and North America. In addition to marketing its own products, the company also offers technologies and expertise for the development and marketing of probiotic and prebiotic products. OptiBiotix Health has solidified its successes by winning a number of awards. In 2019, the company won the Health Investor award for "Pharma/Technology Deal of the Year" for its partnership with Seed Health LLC, and in 2020, its online group "OptiBiotix Health PLC Forum" was nominated for the "Best Informative Forum Award" at the British Online Awards. The vision of OptiBiotix Health is to improve the health and well-being of people by developing and marketing innovative and effective products and technologies. The company is committed to scientific thinking and continuous innovation to fully harness the potential of probiotic and prebiotic products. OptiBiotix Health is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing OptiBiotix Health's EBIT

OptiBiotix Health's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of OptiBiotix Health's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

OptiBiotix Health's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in OptiBiotix Health’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about OptiBiotix Health stock

EBIT of OptiBiotix Health is -3.13 M GBP in 2025.

EBIT of OptiBiotix Health changed from -2.27 M GBP to -3.13 M GBP, representing a 38.22% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT OptiBiotix Health since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's GBP is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's OptiBiotix Health historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — OptiBiotix Health

All Key Metrics — OptiBiotix Health